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Abstract  Pseudomonas  aeruginosa  colonizes  the  lungs  in  cystic  ﬁbrosis  (CF)  and
mechanically  ventilated  patients  by  binding  to  the  cellular  receptors  on  the  sur-
face  of  the  lung  epithelium.  Studies  have  shown  that  blocking  this  interaction
could  be  achieved  with  sub-minimum  inhibitory  concentrations  of  antibiotics  such
as  ciproﬂoxacin.  The  development  of  bacterial  resistance  is  a  probable  drawback  of
such  an  intervention.  The  use  of  natural  extracts  to  interfere  with  bacterial  adhesion
and  invasion  has  recently  gained  substantial  attention  and  is  hypothesized  to  inhibit
bacterial  binding  and  consequently  prevent  or  reduce  pathogenicity.  This  study  used
an  A549  lung  epithelial  cell  infection  model,  and  the  results  revealed  that  a combi-
nation  of  aqueous  cranberry  extract  with  ciproﬂoxacin  could  completely  prevent  the
adhesion  and  invasion  of  P.  aeruginosa  PAO1  compared  to  the  untreated  control.  All
of  the  natural  extracts  (cranberry,  dextran,  and  soybean  extracts)  and  ciproﬂoxacin
showed  a  signiﬁcant  reduction  (P  <  0.0001)  in  P.  aeruginosa  PAO1  adhesion  to  and
invasion  of  lung  epithelial  cells  relative  to  the  control.  The  cranberry,  dextran,  and
soybean  extracts  could  substantially  increase  the  anti-adhesion  and  anti-invasion
effects  of  ciproﬂoxacin  to  the  averages  of  100%  (P  <  0.0001),  80%  (P  <  0.0001),  and
60%  (P  <  0.0001),  respectively.  Those  extracts  might  result  in  a  lower  rate  of  the
Abbreviations: ANOVA, analysis of variance; ATCC, American type culture collection; CAMHB, cation adjusted Mueller Hinton
broth; CF, cystic ﬁbrosis; CLSI, Clinical and Laboratory Standards Institute; COPD, chronic obstructive pulmonary disease; FBS, fetal
bovine serum; MCC, minimum cytotoxic concentration; MIC, minimum inhibitory concentration; PBS, phosphate-buffered saline; S.D.,
standard deviation; SEM, scanning electron microscopy.
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development  of  bacterial  resistance;  they  are  relatively  safe  and  inexpensive  agents,
and  utilizing  such  extracts,  alone  or  in  combination  with  ciproﬂoxacin,  as  potential
vasion  remedies,  could  be  valuable  in  preventing  or  reducing
ions.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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chased  from  Sigma—Aldrich  (St.  Louis,  MO,  USA),
and their  stock  solutions  were  prepared  in  0.1  N  HCl
(32 mg/ml)  and  water  (32  mg/ml),  respectively,  andanti-adhesion  and  anti-in
P.  aeruginosa  lung  infect
©  2014  King  Saud  Bin  Ab
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ntroduction
seudomonas  aeruginosa  is  an  important  human
athogen  that  causes  a  wide  range  of  infectious
iseases that  are  associated  with  high  morbidity
nd mortality  rates  [1—4]. P.  aeruginosa  surface
actors, such  as  pili,  lectins  and  other  adhesins,
dhere and  interact  with  airway  epithelial  cells
f cystic  ﬁbrosis  patients.  The  components  of  the
nnate immune  system  thought  to  be  essential  in
he P.  aeruginosa—epithelial  cell  interaction  are
he toll-like  receptors  that  respond  to  conserved
acterial components,  such  as  peptidoglycan  and
ipopolysaccharides,  and  facilitate  bacterial  recog-
ition and  subsequent  inﬂammatory  responses  [5].
Adhesion  of  P.  aeruginosa  to  the  airway  cellular
eceptors is  the  initial  event  in  the  establishment
f respiratory  colonization  and  subsequent  chronic
nfection  [2,5,6].  The  afﬁnity  of  P.  aeruginosa  to
ind to  the  inﬂamed  or  injured  epithelial  cells
CF or  mechanically  ventilated  patients)  is  signif-
cantly  higher  than  the  afﬁnity  to  bind  to  normal
ell surfaces;  preventing  bacterial  adherence  might
inimize  lung  pathology  in  high-risk  patients  [6].
The use  of  natural  compounds,  especially  carbo-
ydrates,  to  prevent  infection  has  been  considered
n lung  infectivity  studies  because  bacteria  asso-
iated  with  pneumonia  is  known  to  bind  to  the
arbohydrate receptors  on  the  pulmonary  epithe-
ium [2].  Dextran,  a  polymer  of    (1,6)  linked
-glucose  (branched  at  the  three  position),  is  a
idely available  polysaccharide  that  has  been  used
n in  vitro  and  in  vivo  infection  models  to  block  the
dherence  of  P.  aeruginosa, Haemophilus  inﬂuen-
ae and  Staphylococcus  aureus  [2,5].  Berries  of
he Vaccinium  family  (including  cranberry)  and
heir extracts  containing  an  effective  saccharide
ould prevent  the  attachment  of  Escherichia  coli
o uroepithelial  receptors  [2].
Recent  studies  suggested  that  many  pathogenic
rganisms have  the  ability  to  invade  and  reside  in
ost cells  during  the  early  stage  of  infection.  The
iscovery  of  antibiotic-resistant  intracellular  H.
nﬂuenzae  in  the  lungs  of  individuals  with  chronic
bstructive pulmonary  disease  (COPD)  implicates
s
t
(ntracellular  bacteria  as  a  crucial  reservoir  for  per-
istent infection  [7]. P.  aeruginosa  could  survive
or up  to  24  h  inside  the  lung  epithelium  without
nducing cytotoxicity,  and  it  develops  resistance  to
reatment afterwards  [7]. It  is  equally  important
o combat  bacterial  adhesion  and  invasion  for  pre-
enting infection  and  the  development  of  bacterial
esistance.
Some  inexpensive  natural  extracts  (e.g.,  the
erries  of  the  Vaccinium  family  and  dextran)  have
hown promising  anti-adhesion  properties  with
ome micro-organisms  (e.g.,  E.  coli)  in  urinary
ract infections;  they  might  merit  testing  as  topi-
al therapeutics  for  the  prevention  of  P.  aeruginosa
dhesion to  and  invasion  of  lung  epithelial  cells
8,9]. Fluoroquinolones  could  prevent  adhesion  and
ioﬁlm formation  of  some  urinary  pathogens  [10],
nd incubation  of  some  uropathogens  with  sub-
nhibitory  concentrations  of  ciproﬂoxacin  reduces
he capacity  of  the  tested  microorganisms  to
dhere  to  uroepithelial  cells  [11].  Sub-inhibitory
oncentrations  of  ciproﬂoxacin  have  the  ability  to
lter bacterial  surface  structures  and  modulate  the
dherence  of  respiratory  pathogens  to  bronchial
pithelial cells  by  affecting  the  expression  of  micro-
ial adhesins  of  P.  aeruginosa  [12].
In this  study,  certain  natural  extracts  with  poten-
ial anti-adhesion  properties,  both  alone  and  in
ombination  with  ciproﬂoxacin,  were  evaluated
s blocking  agents  against  P. aeruginosa  PAO1
dhesion to  and  invasion  of  A549  lung  epithelial
ells.
ethods
eagents
iproﬂoxacin  and  gentamicin  sulfate  were  pur-tored at  −80 ◦C.  Before  use,  the  antibiotic  dilu-
ions were  prepared  in  F12-K  cell  culture  medium
Cellgro, Mediatech,  Inc.,  Manassas,  VA,  USA).  The
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other  cell  culture  reagents  were  obtained  from
Cellgro, Mediatech,  Inc.  (Manassas,  VA,  USA).  The
40,000-Da  molecular  weight  dextran  was  kindly  pro-
vided by  Dr.  John  Brekke  (University  of  Minnesota,
Duluth, MN,  USA).  The  bacterial  culture  reagents
were obtained  from  Difco  Laboratories  (Detroit,  MI,
USA).
Preparation of the aqueous natural extracts
The  aqueous  extracts  used  in  this  study  were
prepared according  to  the  method  described  by
Johnson  et  al.  [13], with  some  modiﬁcations.
Brieﬂy, commercially  available  Vaccinium  macro-
carpon  (cranberries)  and  Glycine  max  (soybeans)
were washed,  pulverized,  and  extracted  with  ster-
ile water  (1:1  and  1:3.5,  respectively)  at  room
temperature. The  crude  mixtures  were  left  to
decant overnight  at  4 ◦C.  Their  supernatants  were
subjected  to  two-step  centrifugation  at  4750  rpm
for 20  min,  followed  by  12,000  rpm  for  10  min.
The resultant  supernatants  were  membrane  ﬁl-
tered (0.22  m,  Millipore  Corp.  Billerica,  MA,  USA).
The sterile  extracts  were  stored  at  −80 ◦C  in  1-
ml aliquots  until  they  were  used  in  the  adhesion
or invasion  assays.  The  concentrations  of  the  solu-
ble ingredients  of  the  extracts  were  determined  by
evaporating  the  water  content  at  40 ◦C  and  weigh-
ing the  solid  residues  until  constant  weights  were
achieved;  the  original  concentrations  of  the  soluble
ingredients  were  expressed  as  mg/ml.
Bacterial strain and growth conditions
P.  aeruginosa  strain  PAO1  (ATCC  15692)  samples
were purchased  from  the  American  Type  Cul-
ture Collection  (ATCC,  Rockville,  MD,  USA).  The
P. aeruginosa  PAO1  was  grown  until  it  achieved
the exponential  growth  phase  over  16  h  at  37 ◦C
in Cation  Adjusted  Mueller  Hinton  Broth  (CAMHB)
(Sigma—Aldrich, St.  Louis.  MO,  USA),  from  which  a
0.5 McFarland  (1.5  ×  108 CFU/ml)  equivalent  tube
(Thermo  Scientiﬁc  RemelTM,  Lenexa,  KS,  USA)  was
prepared  in  F12-K  tissue  culture  medium  to  initiate
the adhesion  or  invasion  assays.
Cell culture
The  A549  lung  epithelial  cell  line  was  obtained
from the  American  Type  Culture  Collection  (ATCC,
Rockville,  MD,  USA).  The  cells  were  passed  in  75  cm2
ﬂasks  (BD  Falcon,  San  Jose,  CA,  USA),  and  the
51.5 ×  10 cells  were  counted  using  an  hemocytome-
ter and  seeded  into  12-well  tissue  culture  plates
(Becton Dickinson,  NJ,  USA).  The  cells  were  incu-
bated in  F12-K  medium  supplemented  with  10%
e
v
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v/v)  Fetal  Bovine  Serum  (FBS)  at  37 ◦C  in  the  pres-
nce of  5%  CO2 to  achieve  a  conﬂuent  monolayer
ver 48  h.
etermination of MIC and MCC
he  minimum  inhibitory  concentration  (MIC)  and
inimum  cytotoxic  concentration  (MCC)  were  two
actors that  controlled  the  choice  of  the  extract  or
iproﬂoxacin  concentrations  selected  in  the  adhe-
ion and  invasion  assays.  To  prevent  adhesion  or
nvasion, the  bacterial  cells  should  be  alive  but
ncapable  of  clinging  to  or  intruding  into  the  lung
pithelial  cells;  it  was  necessary  to  determine
he sub-MIC  prior  to  the  assays.  The  lung  cell
ntegrity was  kept  intact  using  a  sub-MCC  of  the
ested agents.  The  MICs  were  determined  accord-
ng to  the  CLSI  guidelines  [14]. The  cytotoxicity  of
he tested  agents  against  the  A549  lung  epithe-
ial cell  line  was  determined  using  the  crystal
iolet staining  method  described  by  Gillies  et  al.
15], with  minor  modiﬁcations.  Brieﬂy,  a  conﬂu-
nt monolayer  of  A549  lung  epithelial  cells  was
ncubated  for  2  h  with  200  l  of  twofold  serial  dilu-
ions of  different  test  agents  prepared  in  F12-K
edium,  and  then  the  cells  were  washed  twice
ith phosphate-buffered  saline  (PBS).  After  rinsing,
he cells  were  ﬁxed  with  1%  (v/v)  glutaraldehyde
Sigma—Aldrich,  St.  Louis,  MO,  USA)  and  stained
ith 0.1%  (w/v)  crystal  violet  (Fisher  Scientiﬁc,
ittsburgh, PA,  USA)  for  15  min.  The  dye  was
emoved by  multiple  sterile  water  rinses,  and  the
bsorbed  crystal  violet  was  then  dissolved  with  0.5%
v/v) Triton  X-100  (Sigma—Aldrich,  St.  Louis,  MO,
SA).
The absorbance  was  measured  at  590  nm  using  a
ynergyTM2 Microplate  Reader  (BioTech  Instruments
nc., Winooski,  VT,  USA).  The  absorbance  data  were
nalyzed  using  Excel  software,  and  the  sub-MCCs
ere determined  for  the  tested  agents.
canning electron microscopy (SEM)
or  the  SEM  analysis,  A549  lung  epithelial  cells
ere challenged  with  P.  aeruginosa  PAO1  cells  for
 h,  washed  three  times  with  F12-K  medium  and
ubsequently  ﬁxed  with  5%  (v/v)  glutaraldehyde
ver 24  h.  The  cells  were  then  ﬂushed  with  sterile
eionized water  to  remove  salts  and  dried  before
canning with  a  JSM-6490LV  SEM  (Peabody,  MA,  USA)
quipped with  a tungsten  ﬁlament,  accelerating
oltages of  15—20  kV  and  a  chamber  pressure  of
0—70 Pa,  according  to  the  method  described  by
arterson  et  al.,  with  minor  adaptations  [16].
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Mnhibition  of  PAO1  adhesion  and  invasion  of  A549  by
dhesion assay
he  infectivity  experiments  were  conducted  in  a
terile class  II  biological  safety  cabinet  (Sterilgard
II Advance,  Baker  Company,  Sanford,  ME,  USA)
ccording  to  the  method  described  by  Plotkowski
t al.  [17],  with  some  modiﬁcations.  Initially,  the
onﬂuent  monolayer  of  A549  lung  epithelial  cells
as incubated  with  500  l  of  fresh  F12-K  cell
ulture medium  (control  wells),  500  l of  a nat-
ral extract  or  combination  solutions  (a  natural
xtract and  ciproﬂoxacin)  in  F12-K  medium  at
7 ◦C  for  15  min,  followed  by  mixing  with  500  l
f a  0.5  McFarland  (1.5  ×  108 CFU/ml)  equiva-
ent suspension  of  P.  aeruginosa  PAO1  prepared
n F12-K  medium  for  1  min  to  achieve  a  homoge-
ous bacterial  distribution  in  MultiwellTM 12-well
issue culture  plates  (Becton  Dickinson,  NJ,  USA).
iproﬂoxacin  (0.063  g/ml),  dextran  (5.0  mg/ml),
nd aqueous  soybean  (4.3  mg/ml)  and  cranberry
2.6 mg/ml)  extracts  as  well  as  combinations  of  the
hree latter  agents  with  ciproﬂoxacin  were  applied
s potential  anti-adhesion  agents  in  the  aforemen-
ioned  assay.  The  mixture  was  incubated  at  37 ◦C
or 1  h to  establish  bacterial  adhesion.  Each  plate
ad a  control  well,  and  all  of  the  experiments  were
onducted  in  triplicate.
At  the  end  of  the  incubation,  the  cells  were  gen-
ly washed  three  times  with  FBS  free  F12-K  medium
o eliminate  the  non-adhered  P.  aeruginosa  PAO1
acterial  cells,  and  lysis  of  the  mammalian  cells  was
arried out  with  1  ml  of  1%  (v/v)  Tween-20  (Astoria-
aciﬁc, Clackamas,  OR,  USA)  at  37 ◦C  for  30  min.
After  the  lysis,  10-fold  serial  dilutions  of  the  P.
eruginosa  PAO1  suspension  in  each  well  were  car-
ied out,  followed  by  plating  onto  CAMHII  agar.  The
AMHII agar  plates  were  incubated  at  37 ◦C  for  18  h
o determine  the  CFU/ml  through  viable  cell  count-
ng of  the  treatments  as  well  as  of  the  untreated
ontrol.
nvasion assay
he  parallel  experiments  were  carried  out  as
escribed  under  the  adhesion  assay  except  for  an
xtra step  performed  to  assess  the  P.  aeruginosa
AO1 invasion  into  the  A549  lung  epithelial  cells.
fter a  15-min  incubation  with  500  l  of  the  drug
r the  combination  solutions  in  F12-K  medium
t 37 ◦C,  a  bacterial  suspension  (500  l  of  0.5
cFarland equivalent  suspension)  was  added  and
ixed with  the  aforementioned  solutions  for  1  min
TMn Multiwell 12-well  tissue  culture  plates.  The
lates were  incubated  at  37 ◦C  for  2 h  to  permit  bac-
erial  invasion.  The  gentamicin  exclusion  method  as
escribed by  Fleiszig  et  al.  [18]  was  used  to  kill  the
e
T
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dherent  bacterial  cells.  This  step  involved  wash-
ng the  adherent  cells  with  FBS  free  F12-K  medium,
ollowed by  incubation  of  the  infected  cells  with
resh F12-K  medium  containing  300-g/ml  genta-
icin for  1  h  at  37 ◦C.  After  incubation,  the  dead
acteria were  washed  three  times  with  FBS  free
12-K medium,  and  the  A549  lung  epithelial  cells
ere lysed  with  a 1%  (v/v)  Tween-20  solution  to
etermine  the  number  of  internalized  P.  aeruginosa
AO1 cells.  The  resultant  cell  suspensions  were  seri-
lly diluted  10-fold,  plated  onto  CAMHII  agar  plates,
nd incubated,  as  previously  described  under  the
dhesion assay.
tatistical analysis
he  percentages  of  adhesion  and  invasion  for
ach treatment  relative  to  the  untreated  controls
ere  calculated,  and  the  averages  of  the  tripli-
ate experiments  were  expressed  graphically  ±  the
tandard deviations  (S.D.).  The  data  were  analyzed
sing  Graphpad  prism  5  software  (GraphPad  Soft-
are Inc.,  La  Jolla,  CA,  USA)  that  utilized  one-way
NOVA followed  by  the  Dunnett  Multiple  Compari-
on adjustment  to  determine  the  signiﬁcance  of  the
reatment  differences  on  the  adhesion  and  invasion
f P.  aeruginosa  PAO1,  compared  to  the  controls.
esults
dhesion of P. aeruginosa PAO1 to the lung
pithelial cells
he  adhesion  of  P.  aeruginosa  PAO1  to  the  A549  lung
pithelial cells  was  visualized  using  SEM.  The  imag-
ng revealed  that  P.  aeruginosa  PAO1  could  adhere
o lung  epithelial  cells  without  disrupting  the  lung
ell integrity  or morphology  (Fig.  1).
oncentrations of  the soluble ingredients in
he aqueous extracts
he  soluble  ingredients  for  the  tested  extracts  were
etermined  as  described  in  Methods  section,  and
heir original  concentrations  were  50.9  mg/ml  and
5.7 mg/ml  for  the  aqueous  cranberry  and  soybean
xtracts,  respectively.  Dextran  was  applied  at  a
oncentration  level  of  5.0  mg/ml.
IC and MCC of ciproﬂoxacin and natural
xtracts
he  MIC  of  ciproﬂoxacin  and  the  natural  extracts
gainst P.  aeruginosa  PAO1  and  the  MCC  of  the
440  
Fig.  1  Scanning  electron  micrograph  illustrating  the
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(adherence  of  Pseudomonas  aeruginosa  PAO1  to  A549  lung
epithelial  cells.
identical  agents  on  the  A549  lung  epithelial  cells
are shown  in  Table  1.  The  relatively  high  concen-
trations of  the  MICs  against  P.  aeruginosa  PAO1  and
those of  MCC  on  A549  lung  epithelial  cells  might
indicate that  these  agents  are  fairly  non-toxic  to
A549 lung  epithelial  cells  as  well  as  being  unable
to inhibit  the  growth  of  P.  aeruginosa  PAO1  at  the
tested  concentrations.
Based  on  the  data  shown  in  Table  1,  the  sub-
MIC and  sub-MCC  concentrations  of  ciproﬂoxacin
and the  natural  extracts  were  selected  in  the  adhe-
sion and  invasion  assays  to  evaluate  their  effects,  as
single agents  or  in  combination  with  ciproﬂoxacin,
on P.  aeruginosa  PAO1  adhesion  and  invasion,  with-
out interfering  with  the  viability  of  the  bacterial  or
mammalian  cells.  Ciproﬂoxacin  (0.063  g/ml),  dex-
tran (5.0  mg/ml),  cranberry  extract  (2.6  mg/ml),
and soybean  extract  (4.3  mg/ml)  were  selected  at
their sub-MIC/sub-MCC  concentrations  for  assessing
the effects  of  the  single  treatments  on  P.  aeruginosa
PAO1 adhesion  and  invasion  of  lung  epithelial
cells. In  the  combination  treatments,  the  effect
of ciproﬂoxacin  (0.063  g/ml)  on  the  adhesion  and
invasion of  P.  aeruginosa  PAO1  was  assessed  with  the
Table  1  MIC  and  MCC  values  of  ciproﬂoxacin  and  the
tested  natural  extracts  against  P.  aeruginosa  PAO1  and
A549  lung  epithelial  cells,  respectively.
Treatment  MICa (g/ml)  MCCb (g/ml)
Ciproﬂoxacin  0.125  >64
Dextran  >10  000  >10  000
Cranberry  extract  >5090  >5090
Soybean  extract  >8570  >8570
a Minimum inhibitory concentration.
b Minimum cytotoxic concentration.
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forementioned  concentrations  of  the  tested  single
gents at  levels  of  50%.
ffect of natural extracts and their
ombinations with ciproﬂoxacin on the
dhesion of P. aeruginosa PAO1 to A549
ung epithelial cells
dhesion  of  P.  aeruginosa  PAO1  to  the  lung  epithe-
ial cells  was  assessed  through  viable  cell  counting
f the  bacteria  bound  to  the  cell  surface  from
ach independent  triplicate  experiment  and  the
ntreated  controls.  Adhesion  of  P.  aeruginosa  PAO1
o the  A549  lung  epithelial  cells  in  the  presence
f natural  extracts,  as  single  agents  and  in  com-
ination  with  ciproﬂoxacin,  was  expressed  as  the
ercentage  of  adhered  bacterial  cells  to  the  epithe-
ial cell  surface  and  normalized  to  that  of  the
ntreated controls.  Ciproﬂoxacin  (0.063  g/ml),
extran  (5.0  mg/ml),  soybean  extract  (4.3  mg/ml),
nd cranberry  extract  (2.6  mg/ml)  could  reduce  P.
eruginosa  PAO1  adhesion  by  26.3%,  16.4%,  45.2%,
nd 54.5%,  respectively,  compared  to  the  untreated
ontrol. Ciproﬂoxacin  in  combination  with  dex-
ran (2.5  mg/ml),  soybean  extract  (2.1  mg/ml),
nd cranberry  extract  (1.3  mg/ml)  could  reduce
. aeruginosa  PAO1  adhesion  by  87.5%,  72.2%,
nd 100%,  respectively,  compared  to  the  con-
rol (Fig.  2).  The  combination  of  ciproﬂoxacin
0.063 g/ml)  with  cranberry  extract  (1.3  mg/ml)
ould  completely  (0.0%)  inhibit  the  adhesion  of
. aeruginosa  PAO1  to  A549  lung  epithelial  cells.
lthough  dextran  was  relatively  the  least  effective
ingle anti-adhesion  treatment  (83.6%  ±  12.1%),  it
chieved a  signiﬁcantly  higher  effect  in  combina-
ion with  ciproﬂoxacin  (12.5%  ±  4.2%).
Soybean extract  was  an  effective  anti-adhesion
gent (54.8%  ± 6.4%)  compared  to  ciproﬂoxacin
73.7% ±  2.08%),  and  their  combination  could
ynergistically (27.8%  ±  0.65%)  and  signiﬁcantly
P <  0.0001)  reduce  the  ability  of  P.  aeruginosa  PAO1
o adhere  to  the  A549  lung  epithelial  cells  (Fig.  2).
ffect of natural extracts and their
ombinations with ciproﬂoxacin on the
nvasion of P. aeruginosa PAO1 to  A549 lung
pithelial cells
he  ability  of  adhered  bacterial  cells  to  internalize
nto lung  epithelial  cells  in  the  presence  of  natural
xtracts,  as  single  agents  or  in  combination  with
iproﬂoxacin,  was  assessed  through  calculation  of
he percentage  of  the  invasion  of  P.  aeruginosa
AO1 from  three  independent  experiments  rela-
ive to  the  untreated  controls.  The  results  of  the
Inhibition  of  PAO1  adhesion  and  invasion  of  A549  by  natural  extracts  441
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aig.  2  The  effect  of  different  natural  extracts  alone  a
eruginosa  PAO1  to  A549  lung  epithelial  cells  as  compare
entamicin  exclusion  assay  reﬂect  the  counts
f bacteria  that  could  invade  the  lung  epithe-
ial cells  with  different  treatments.  Cranberry
xtract alone  and  in  combination  with  ciproﬂoxacin
ould completely  (0.0%)  abrogate  the  invasion  of
. aeruginosa  PAO1  to  the  lung  cells.  Although
5.5% ±  6.7%  of  the  initial  bacterial  inoculum
as able  to  bind  to  the  epithelial  cells  after
reatment with  cranberry  extract,  none  of this
dhered  population  was  able  to  penetrate  the
ung epithelial  cells.  Following  the  synergistic
ffect of  cranberry  extract,  the  combination  of
iproﬂoxacin  with  soybean  (11.8%  ±  2.1%)  and  dex-
ran (16.4%  ±  7.12%)  extracts  achieved  comparable
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 the  untreated  control.
nd  signiﬁcant  (P  < 0.0001)  anti-invasion  effects
ompared to  the  control.  In  results  similar  to  those
rom the  adhesion  assay,  dextran  and  soybean  were
ore effective  in  combination  with  ciproﬂoxacin
n preventing  invasion  rather  than  as  single  agents
75.5%  ±  2.1%)  and  (18.6%  ±  11.8%),  respectively
Fig.  3).
iscussion.  aeruginosa  is  a  major  cause  of  mortality  reported
n CF  patients  [6]. The  adhesion  and  subsequent
nvasion of  the  organism  in  the  lung  epithelial  cells
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are  the  initial  and  signiﬁcant  steps  in  lung  infections
[5,19—21].  Once  colonization  of  the  organism  is
established,  it  is  rarely  eradicated.  Several  strate-
gies have  been  developed  to  prevent  P.  aeruginosa
infection in  CF  patients  through  antibiotics  and
immunizations,  but  they  have  not  been  successful
[8,22—24].  The  development  of  other  prophylactic
measures such  as  anti-adhesion  and  anti-invasion
approaches is  required.  Ciproﬂoxacin,  a ﬂuoro-
quinolone, is  considered  the  antibiotic  of  choice  for
the treatment  of  lung  infections  from  P.  aeruginosa
[7].  This  study  aimed  at  introducing  a  new  strategy
to prevent  P.  aeruginosa  adhesion  to  and  invasion
of lung  epithelial  cells  using  different  combina-
tions of  ciproﬂoxacin  and  aqueous  extracts  from
widely  available  natural  products  such  as  cranber-
ries and  soybeans.  Dextran,  which  has  been  tested
in some  studies  and  found  to  be  an  effective  anti-
adhesion agent  [2,8,16], was  also  assessed  on  an
epithelial  cell  infection  model  to  evaluate  its  anti-
adhesion  and  anti-invasion  activities,  compared  to
other natural  products,  alone  and  in  combination
with ciproﬂoxacin.
The virulence  factors  of  different  P.  aeruginosa
strains were  attributed  to  their  direct  host  cell
cytotoxicity  or  their  ability  to  adhere  to,  invade,
and survive  in  epithelial  cells.  P.  aeruginosa  PAO1
virulence  is  categorized  by  two  types  of  isolates,
and it  was  suggested  that  the  invasion  of  this  strain
contributes  to  bioﬁlm  formation  and  the  establish-
ment  of  chronic  lung  infections  [7].  The  binding
of P.  aeruginosa  to  uninjured  epithelial  surfaces
was found  to  be  minimal.  The  binding  ability  of
the organism  increases  dramatically  in  the  pres-
ence of  epithelial  surface  inﬂammation  or  injury
such as  is found  in  CF  patients  [6,25].  Imaging
with SEM  revealed  that  the  binding  of  P.  aeruginosa
PAO1 to  lung  epithelial  cells  is the  ﬁrst  step  of  P.
aeruginosa  infection.  Such  binding  did  not  affect
the integrity  or  morphology  of  the  cells  (Fig.  1).
Similarly,  Fleiszig  et  al.  [18]  noted  that  the  integrity
of the  infected  cells  remains  unaffected  because
the P.  aeruginosa  PAO1  strain  shows  no  direct  cyto-
toxicity,  as  a  virulence  mechanism,  against  lung
epithelial  cells.  To  exclude  the  inhibitory  effect
of ciproﬂoxacin  and  the  applied  natural  extracts
on P.  aeruginosa  PAO1  and  the  A549  lung  epithe-
lial cells,  the  MICs  of  ciproﬂoxacin  and  the  natural
extracts against  P.  aeruginosa  PAO1  and  the  MCCs
of the  identical  agents  were  determined  to  aid
the selection  of  the  concentrations  of  different
agents for  their  testing  on  the  adhesion  and  invasion
models.
The MIC  and  MCC  values  could  not  be  reached
within the  tested  concentration  levels  of  the  natu-
ral extracts,  which  were  relatively  high  compared
e
5
a
cG.F.  Ahmed  et  al.
o  ciproﬂoxacin,  indicating  that  they  are  relatively
on-toxic  to  A549  lung  epithelial  cells  as  well  as
o P.  aeruginosa  PAO1.  Extracts  of  natural  sources
re unlimited  reservoirs  of  safe  and  relatively  inex-
ensive bioactive  agents  [9]. Dextran  is  a  widely
vailable  polysaccharide  that  has  been  used  in  clin-
cal settings  as  a  plasma  expander,  and  it  was
reviously  tested  as  a carbohydrate  treatment  that
locks epithelial  glycoconjugates  and  impedes  bac-
erial legends  from  binding  to  pulmonary  epithelial
ell receptors  [2]. Aerosolized  dextran  has  been
xamined  in  a mouse  infection  model  to  prevent
. aeruginosa  associated  pneumonia,  and  it  could
igniﬁcantly  reduce  the  development  of  pneumo-
ia in  the  treated  group  relative  to  the  untreated
ontrol animals,  because  it is  an  immuno-stimulant
nd sputum  rheology  enhancer  [2].
The combination  treatment  of  dextran  with
iproﬂoxacin disabled  the  internalization  ability  of
pproximately  85%  of  the  bacterial  population  that
dhered in  the  control  experiments.  The  appli-
ation  of  dextran  resulted  on  average  in  a  14%
eduction in  adhesion  to  and  invasion  of  the  lung
pithelial  cells  by  P.  aeruginosa  PAO1.  This  reduc-
ion is less  than  that  described  by  Bryan  et  al.
2], who  reported  a 35%  reduction  of  P.  aeruginosa
AO1 adhesion  to  nasal  polyp  primary  culture  cells
hen pretreated  with  dextran.  Factors  such  as  the
ifference in  the  cell  culture  type  or  the  exper-
mental conditions  might  explain  the  disparity  in
he activities.  The  authors  proposed  that  the  likely
echanism  through  which  dextran  blocks  bacte-
ial adhesion  was  through  non-speciﬁc  interaction
ith epithelial  cells  because  the  pre-incubation  of
. aeruginosa  PAO1  with  dextran  before  performing
he infection  abolished  its  anti-adhesion  proper-
ies [2].  The  inhibitory  action  of  dextran  might
ot only  involve  P.  aeruginosa  PAO1  adhesion;  it
ight involve  other  potential  pathogens  as  well,
specially  those  targeting  the  respiratory  epithelial
ells.
To our  knowledge,  no  studies  have  reported  the
se of  soybean  extract  as  a  potential  anti-adhesion
r anti-invasion  treatment.  This  study  proposes
hat aqueous  soybean  (G.  max)  extract  is  an  addi-
ional promising  treatment  against  the  adhesion
nd invasion  of  P.  aeruginosa  PAO1  in  lung  epithelial
ells.
Comparing  to  the  control,  28%  and  12%,  respec-
ively, of  the  applied  bacterial  inoculum  could
dhere to  and  invade  the  lung  epithelial  cells  in
ase of  ciproﬂoxacin  combination  with  soybean
xtract. These  results  suggest  that  approximately
7% of  the  bacterial  population  that  was  able  to
dhere became  unable  to  invade  the  lung  epithelial
ells  with  such  combination.
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against urinary pathogens. J Antimicrob Chemother
2001;48(1):37—45.
[12] Ferrara A, Dos Santos C, Lupi A. Effect of different antibac-nhibition  of  PAO1  adhesion  and  invasion  of  A549  by
An  aqueous  cranberry  (V.  macrocarpon)  extract
as the  most  effective  anti-adhesion  and  anti-
nvasion  treatment  when  used  in  combination  with
iproﬂoxacin.  Cranberry  belongs  to  the  Vaccinium
amily, which  has  a  wide  spectrum  of  in  vitro
ntimicrobial activity  [26]. Many  reports  have
emonstrated  that  the  proanthocyanidins  and  sac-
harides of  cranberries  inhibit  the  adhesion  and
nvasion  of  pathogenic  microbes  in  vitro,  and  that
ranberry  juice  clinically  prevents  urinary  tract
nfection  in  women  by  inhibiting  E.  coli  adhesion
o the  uroepithelial  glycolipid  receptors.  Cran-
erry extract  protects  against  resistant  strains  of
. coli  by  a  mechanism  that  is  unlikely  to  increase
he selective  pressure  associated  with  antibi-
tic resistance  [9]. Combining  cranberry  extract
ith ciproﬂoxacin  sub-MIC  might  block  the  ini-
ial steps  of  infection,  adhesion  and  invasion,  as
ell as  minimize  the  development  of  bacterial
esistance.
The results  of  this  study  might  indicate
hat cranberry  extract  could  deter  the  adhered
acteria from  invading  the  lung  epithelial  cells
ecause  around  45%  of  the  P.  aeruginosa  PAO1
opulation that  were  able  to  adhere  to  lung
ells rendered  incapable  of  invading  those  cells
fter treatment  with  cranberry  extract.  Further
olecular studies  are  required  to  elucidate  this
nding.
In a  published  randomized  clinical  trial,  cran-
erry juice  was  found  to  affect  only  harmful
acteria, leaving  normal  bacterial  ﬂora  unaf-
ected, which  suggests  that  cranberries  have
herapeutic  beneﬁts  without  major  unexpected
ide effects  [26]. Cranberry  juice,  capsules
nd powder  were  found  to  reduce  urinary
ract infection  recurrences  as  well  as  salival
ounts of  the  bacteria  that  cause  dental  carries
26—29].
Proposing  anti-adhesion  treatments  is  signiﬁ-
ant because  the  earlier  an  airway  infection  is
revented,  the  better  the  expected  therapeutic
utcome; the  persistence  of  intracellular  bacteria
auses  sloughing  of  the  epithelial  cells  containing
hese bacteria  and  might  contribute  to  the  spread
f infection  and  the  establishment  of  a  bioﬁlm,  ren-
ering bacterial  eradication  by  antibiotics  difﬁcult
nd favoring  bacterial  endurance  in  the  host  airway
7].
In light  of  these  in  vitro  anti-adhesion  and
nti-invasion effects  of  promising  natural  extracts,
urther  in  vivo  studies  are  required  to  explore
heir putative  applications  as  an  alternative  strat-
gy for  combating  respiratory  infections  and  their
otential  ability  to  reduce  the  dramatic  increase  in
ntibiotic  resistance.ural  extracts  443
unding
o  funding  sources.
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